Intarcia Therapeutics
USAEntry
–
Hold
–
Exit
2023
Who owns Intarcia Therapeutics?
Intarcia Therapeutics is an American Biotech company, now owned by i2O Therapeutics, which acquired it in 2023 from Quilvest Capital Partners.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Exit Type
Trade Sale
Buyer
i2O Therapeutics
Exit Year
2023
More from QCP Buyout Fund III
Other portfolio companies in the same fund.
France
SwitzerlandMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Intarcia Therapeutics?
Intarcia Therapeutics is now owned by i2O Therapeutics, which acquired it in 2023 from Quilvest Capital Partners.
When did i2O Therapeutics acquire Intarcia Therapeutics?
i2O Therapeutics acquired Intarcia Therapeutics in 2023, buying from Quilvest Capital Partners.
Who did Intarcia Therapeutics sell to?
Quilvest Capital Partners sold Intarcia Therapeutics to i2O Therapeutics in 2023 (Trade Sale).
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue